Search research articles
Contact Us
Filters
Showing results (111-120 of 213) with videos related to
Page
of 22
Sort By:
AJR. American Journal of Roentgenology
|
February 8, 2023
Imaging of Small-Bowel Neuroendocrine Neoplasms: <i>AJR</i> Expert Panel Narrative Review
Patrick J Navin, Eric C Ehman, Jason B Liu, et al.
The Oncologist
|
January 26, 2019
A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)
Thorvardur R Halfdanarson, Nathan R Foster, George P Kim, et al.
JAMA Network Open
|
February 22, 2023
Association Between Survival and Metastatic Site in Mismatch Repair-Deficient Metastatic Colorectal Cancer Treated With First-line Pembrolizumab
Bahar Saberzadeh-Ardestani, Jeremy C Jones, Joleen M Hubbard, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 16, 2025
Incidence and risk of gastric neuroendocrine tumors and adenocarcinoma in patients with atrophic gastritis/pernicious anemia
Rachel V Christenson, Hala Muaddi, Emily Siegler, et al.
American Journal of Surgery
|
September 3, 2020
Comparison of benign and malignant insulinoma
Alaa Sada, Thomas Szabo Yamashita, Amy E Glasgow, et al.
Frontiers in Nuclear Medicine
|
December 12, 2024
Immunohistochemical basis for FAP as a candidate theranostic target across a broad range of cholangiocarcinoma subtypes
Laura C Jorgenson, Michael S Torbenson, Thorvardur R Halfdanarson, et al.
Journal of the American College of Surgeons
|
June 25, 2022
Comparison Between Sporadic and Multiple Endocrine Neoplasia Type 1-Associated Insulinoma
Alaa Sada, Elizabeth B Habermann, Thomas Szabo Yamashita, et al.
American Journal of Clinical Oncology
|
March 18, 2014
The Effect of Receiving Treatment Within a Clinical Trial Setting on Survival and Quality of Care Perception in Advanced Stage Non-Small Cell Lung Cancer
Taher Abu-Hejleh, Elizabeth A Chrischilles, Thorvardur R Halfdanarson, et al.
Theranostics
|
April 22, 2024
Theranostics and artificial intelligence: new frontiers in personalized medicine
Gokce Belge Bilgin, Cem Bilgin, Brian J Burkett, et al.
JCO Precision Oncology
|
July 8, 2024
Clonal Hematopoiesis in Patients With Neuroendocrine Tumor Treated With Lutetium-177 and the Risk of Thrombocytopenia: A Prospective Study
Yael Kusne, Terra Lasho, Christy Finke, et al.
Page
of 22
Search research articles
Search
Showing results (111-120 of 213) with videos related to
Sort By:
Page
of 22
AJR. American Journal of Roentgenology
|
February 8, 2023
Imaging of Small-Bowel Neuroendocrine Neoplasms: <i>AJR</i> Expert Panel Narrative Review
Patrick J Navin, Eric C Ehman, Jason B Liu, et al.
The Oncologist
|
January 26, 2019
A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance)
Thorvardur R Halfdanarson, Nathan R Foster, George P Kim, et al.
JAMA Network Open
|
February 22, 2023
Association Between Survival and Metastatic Site in Mismatch Repair-Deficient Metastatic Colorectal Cancer Treated With First-line Pembrolizumab
Bahar Saberzadeh-Ardestani, Jeremy C Jones, Joleen M Hubbard, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract
|
October 16, 2025
Incidence and risk of gastric neuroendocrine tumors and adenocarcinoma in patients with atrophic gastritis/pernicious anemia
Rachel V Christenson, Hala Muaddi, Emily Siegler, et al.
American Journal of Surgery
|
September 3, 2020
Comparison of benign and malignant insulinoma
Alaa Sada, Thomas Szabo Yamashita, Amy E Glasgow, et al.
Frontiers in Nuclear Medicine
|
December 12, 2024
Immunohistochemical basis for FAP as a candidate theranostic target across a broad range of cholangiocarcinoma subtypes
Laura C Jorgenson, Michael S Torbenson, Thorvardur R Halfdanarson, et al.
Journal of the American College of Surgeons
|
June 25, 2022
Comparison Between Sporadic and Multiple Endocrine Neoplasia Type 1-Associated Insulinoma
Alaa Sada, Elizabeth B Habermann, Thomas Szabo Yamashita, et al.
American Journal of Clinical Oncology
|
March 18, 2014
The Effect of Receiving Treatment Within a Clinical Trial Setting on Survival and Quality of Care Perception in Advanced Stage Non-Small Cell Lung Cancer
Taher Abu-Hejleh, Elizabeth A Chrischilles, Thorvardur R Halfdanarson, et al.
Theranostics
|
April 22, 2024
Theranostics and artificial intelligence: new frontiers in personalized medicine
Gokce Belge Bilgin, Cem Bilgin, Brian J Burkett, et al.
JCO Precision Oncology
|
July 8, 2024
Clonal Hematopoiesis in Patients With Neuroendocrine Tumor Treated With Lutetium-177 and the Risk of Thrombocytopenia: A Prospective Study
Yael Kusne, Terra Lasho, Christy Finke, et al.
Page
of 22